Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis

Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251

Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations

Amann, R., Binder, B. J., Olson, R. J., Chisholm, S. W., Devereux, R., & Stahl, D. A. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.6.1919-1925.1990 · Cited by 4,049

A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY

Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,974

Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria

Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554

Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964

Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria

Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584

Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin

Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,529

Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483

Mucosal flora in inflammatory bowel disease

Swidsinski, A. V., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V. A., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,344

Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment

Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., & SCHLEIFER, K. H. (1996) · Microbiology · doi:10.1099/13500872-142-5-1097 · Cited by 1,176

Long-chain inulin increases dendritic cells in the Peyer's patches and increasesex vivocytokine secretion in the spleen and mesenteric lymph nodes of growing female rats, independent of zinc status

Ryz, N. R., Meddings, J. B., & Taylor, C. G. (2008) · British Journal Of Nutrition · doi:10.1017/s000711450812342x · Cited by 32

Review on the potential application of non-phenolic compounds from native Latin American food byproducts in inflammatory bowel diseases

do Nascimento, R. D. P., Moya, A. M. T. M., Machado, A. P. D. F., Geraldi, M. V., Diez‐Echave, P., Vezza, T., Gálvez, J., Cazarin, C. B. B., & Maróstica, M. R. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109796 · Cited by 32

Plant-Derived Prebiotics and Its Health Benefits

Althubiani, A. S., Alghamdi, S., Samreen, S., Qais, F. A., Khan, M. S., Ahmad, I., & Malak, H. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814619-4.00004-5 · Cited by 32

Probiotic Ameliorating Effects of Altered GABA/Glutamate Signaling in a Rodent Model of Autism

Bin-Khattaf, R. M., Alonazi, M. A., Al-Dbass, A. M., Almnaizel, A. T., Aloudah, H. S., Soliman, D. A., & El-Ansary, A. K. (2022) · Metabolites · doi:10.3390/metabo12080720 · Cited by 30

High-Fiber Diet and Crohn’s Disease: Systematic Review and Meta-Analysis

Serrano-Fernandez, V., Palomino, M. S., Laredo‐Aguilera, J. A., Pozuelo‐Carrascosa, D. P., & Carmona‐Torres, J. M. (2023) · Nutrients · doi:10.3390/nu15143114 · Cited by 32

A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics

Vitetta, L., Briskey, D. R., Hayes, E., Shing, C. M., & Peake, J. M. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0126-8 · Cited by 29

From Gut to Eye: Exploring the Role of Microbiome Imbalance in Ocular Diseases

Tîrziu, A.-T., Șușan, M. M., Șușan, R. M., Sonia, T., Harich, O. O., Tudora, A. G., Varga, N.-I., Dragomir, T. L., Avram, C. R., Boru, C., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185611 · Cited by 33

Chios Mastic Fractions in Experimental Colitis: Implication of the Nuclear Factor κB Pathway in Cultured HT29 Cells

Papalois, A. E., Gioxari, A., Kaliora, A. C., Lymperopoulou, A., Agrogiannis, G. D., Papada, E., & Andrikopoulos, N. K. (2012) · Journal of Medicinal Food · doi:10.1089/jmf.2012.0018 · Cited by 28

Increasing incidence of inflammatory bowel disease in children and adolescents: significance of environmental factors

Park, S., Kang, Y., Koh, H., & Kim, S. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2019.00500 · Cited by 28

The effects and cell barrier mechanism of main dietary nutrients on intestinal barrier

Fan, J., Yang, Y., Ma, C., Liu, X., Wang, Y., Chen, F., Wang, B., Bian, X., Yang, C., & Zhang, N. (2022) · Current Opinion in Food Science · doi:10.1016/j.cofs.2022.100942 · Cited by 28

The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system

Crouch, L. I., Rodrigues, C. S., Bakshani, C. R., Tavares-Gomes, L., Gaifem, J., & Pinho, S. S. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2024.101891 · Cited by 29

Metabolomic analysis of amino acid metabolism in colitic rats supplemented with lactosucrose

Ruan, Z., Lv, Y., Fu, X., He, Q., Deng, Z., Liu, W., Yu, Y., Wu, X., Wu, G., Wu, X., et al. (2013) · Amino Acids · doi:10.1007/s00726-013-1535-8 · Cited by 27

Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis

Kutsuna, R., Tomida, J., Morita, Y., & Kawamura, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197668 · Cited by 27

Chemically modified inulin for intestinal drug delivery – A new dual bioactivity concept for inflammatory bowel disease treatment

Hufnagel, B., Müllner, V., Hlatky, K., Tallian, C., Vielnascher, R., Guebitz, G. M., Wirth, M., & Gabor, F. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117091 · Cited by 30

Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools

Murgiano, M., Bartocci, B., Puca, P., Vincenzo, F. D., GAUDIO, A. D., Papa, A., Cammarota, G., Gasbarrini, A., Scaldaferri, F., & Lopetuso, L. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073059 · Cited by 30

Enteral supplement enriched with glutamine, fiber, and oligosaccharide attenuates experimental colitis in mice

Joo, E., Yamane, S., Hamasaki, A., Harada, N., Matsunaga, T., Muraoka, A., Suzuki, K., Nasteska, D., Fukushima, T., Hayashi, T., et al. (2012) · Nutrition · doi:10.1016/j.nut.2012.09.007 · Cited by 26

Nutraceuticals in rodent models as potential treatments for human Inflammatory Bowel Disease

Ghattamaneni, N. K. R., Panchal, S. K., & Brown, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.015 · Cited by 26

Bioactives and their roles in bone metabolism of osteoarthritis: evidence and mechanisms on gut-bone axis

Basak, S., Hridayanka, K. S. N., & Duttaroy, A. K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1323233 · Cited by 29

Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidence

Ariaee, A., Koentgen, S., Wardill, H. R., Hold, G. L., Prestidge, C. A., Armstrong, H., & Joyce, P. (2024) · eGastroenterology · doi:10.1136/egastro-2023-100055 · Cited by 27

Sex-Specific Differences in the Gut Microbiome in Response to Dietary Fiber Supplementation in IL-10-Deficient Mice

Zhang, Z., Hyun, J. E., Thiesen, A., Park, H., Hotte, N., Watanabe, H., Higashiyama, T., & Madsen, K. L. (2020) · Nutrients · doi:10.3390/nu12072088 · Cited by 26

Gut Microbiota: A Promising Milestone in Enhancing the Efficacy of PD1/PD-L1 Blockade Therapy

Zhou, Y., Liu, Z., & Chen, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.847350 · Cited by 25

Prebiotic inulin‐type fructans: nutritional benefits beyond dietary fibre source

Alexiou, H., & Franck, A. (2008) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2008.00710.x · Cited by 25

Dendritic cells: the yin and yang in disease progression

Jiménez‐Cortegana, C., Palomares, F., Álba, G., Santa‐María, C., de la Cruz‐Merino, L., Sánchez‐Margalet, V., & López-Enríquez, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1321051 · Cited by 24

Diet-Induced Host–Microbe Interactions: Personalized Diet Strategies for Improving Inflammatory Bowel Disease

Lee, J., Kim, K. S., Koh, H., Lee, D.-W., & Kang, N. J. (2022) · Current Developments in Nutrition · doi:10.1093/cdn/nzac110 · Cited by 26

Arabinoxylan and Pectin Metabolism in Crohn’s Disease Microbiota: An In Silico Study

Sabater, C., Calvete‐Torre, I., Ruíz, L., & Margollés, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137093 · Cited by 24

Gut microbiome–based therapeutics in inflammatory bowel disease

Hu, K. A., & Gubatan, J. M. B. (2023) · Clinical and Translational Discovery · doi:10.1002/ctd2.182 · Cited by 25

Prebiotics, Probiotics and Helminths: The ‘Natural’ Solution?

Guarner, F. (2009) · Digestive Diseases · doi:10.1159/000228582 · Cited by 23

Crohn’s disease as an immunodeficiency

Hayee, B., Rahman, F. Z., Sewell, G. W., Smith, A. M., & Segal, A. W. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.32 · Cited by 23

Production of fructooligosaccharides byBacillus subtilisnatto CCT7712 and their antiproliferative potential

Magri, A., de Oliveira, M. R., Baldo, C., Tischer, C. A., Sartori, D., Mantovani, M. S., & Celligoi, M. A. P. C. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14569 · Cited by 22

Inflammatory Bowel Disease

Schölmerich, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.026 · Cited by 23

Prebiotics: types, selectivity and utilization by gut microbes

Yalçıntaş, Y. M., Bolino, M. J., Duman, H., Sarıtaş, S., Pekdemir, B., Kalkan, A. E., Canbolat, A. A., Bolat, E., Eker, F., Rocha, J. M., et al. (2025) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2025.2582557 · Cited by 24

Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation

Fujiwara, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.703298 · Cited by 22

Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance

Fiorindi, C., Russo, E., Balocchini, L., Amedei, A., & Giudici, F. (2022) · Nutrients · doi:10.3390/nu14194117 · Cited by 23

In vitro digestion and fermentation of 5-formyl-aminosailcylate-inulin: A potential prodrug of 5-aminosalicylic acid

Hartzell, A. L., Maldonado-Gómez, M. X., Yang, J., Hutkins, R. W., & Rose, D. J. (2013) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2013.08.001 · Cited by 21

Inulin and Oligofructose

Gibson, G. R., & Delzenne, N. M. (2008) · Nutrition Today · doi:10.1097/01.nt.0000303311.36663.39 · Cited by 21

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease

Mitsuyama, K., & Sata, M. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.3.301 · Cited by 22

Synthesis and engineering of sodium alginate/inulin core-shell nano-hydrogels for controlled-release oral delivery of 5-ASA

Bahadorı, F., Akinan, B. S., Akyıl, S., & Eroğlu, M. S. (2019) · Organic Communications · doi:10.25135/acg.oc.63.19.07.1336 · Cited by 20

Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy—A Narrative Review

Isidori, M., Corbee, R. J., & Trabalza‐Marinucci, M. (2022) · Veterinary Sciences · doi:10.3390/vetsci9020037 · Cited by 24

Components of the Fiber Diet in the Prevention and Treatment of IBD—An Update

Ferenc, K., Jarmakiewicz-Czaja, S., & Filip, R. (2022) · Nutrients · doi:10.3390/nu15010162 · Cited by 21

The gut mucin-microbiota interactions: a missing key to optimizing endurance performance

Clark, A. P., & Mach, N. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1284423 · Cited by 22

Ex Vivo Colonic Fermentation of NUTRIOSE® Exerts Immuno-Modulatory Properties and Strong Anti-Inflammatory Effects

Perreau, C., Thabuis, C., Verstrepen, L., Ghyselinck, J., & Marzorati, M. (2023) · Nutrients · doi:10.3390/nu15194229 · Cited by 20

Oral microbiome dysbiosis and gastrointestinal diseases: a narrative review

El-Ghannam, M., Hassanien, M. H., Ameen, Y. A., Turky, E. A., ELattar, G. M., Ray, A. A. E., & Eltalkawy, M. D. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00340-9 · Cited by 20

Nutrition and inflammatory bowel disease

Tighe, M. P., Cummings, F. J. R., & Afzal, N. A. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328349eb4d · Cited by 19

To Fiber or Not to Fiber: The Swinging Pendulum of Fiber Supplementation in Patients with Inflammatory Bowel Disease

Haskey, N., Gold, S. L., Faith, J. J., & Raman, M. (2023) · Nutrients · doi:10.3390/nu15051080 · Cited by 19

The impact of dietary fermentable carbohydrates on a postinflammatory model of irritable bowel syndrome

Tuck, C. J., Caminero, A., Jiménez-Vargas, N. N., Soltys, C., Polanco, J. O. J., Lopez, C. D. L., Constante, M., Lourenssen, S. R., Verdu, E. F., Muir, J. G., et al. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13675 · Cited by 18

Role of the gut microbiome in psychological symptoms associated with inflammatory bowel diseases

Atanasova, K., Knödler, L.-L., Reindl, W., Ebert, M. P. A., & Thomann, A. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-025-01036-x · Cited by 19

Recent Research and Application Prospect of Functional Oligosaccharides on Intestinal Disease Treatment

Xu, T., Sun, R., Zhang, Y., Zhang, C., Wang, Y., Wang, Z. A., & Du, Y. (2022) · Molecules · doi:10.3390/molecules27217622 · Cited by 18

Supplementation with inulin-type fructans affects gut microbiota and attenuates some of the cardiometabolic benefits of a plant-based diet in individuals with overweight or obesity

Aldubayan, M. A., Mao, X., Laursen, M. F., Pigsborg, K., Christensen, L. H., Roager, H. M., Nielsen, D. S., Hjorth, M. F., & Magkos, F. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1108088 · Cited by 19

Fructooligosaccharides act on the gut–bone axis to improve bone independent of Tregs and alter osteocytes in young adult C57BL/6 female mice

Islam, P., Ice, J. A., Alake, S. E., Adedigba, P. A., Hatter, B., Robinson, K., Clarke, S. L., Versypt, A. N. F., Ritchey, J. W., Lucas, E. A., et al. (2024) · JBMR Plus · doi:10.1093/jbmrpl/ziae021 · Cited by 17

Potential of prebiotics as functional foods – a review

Sarkar, S. (2007) · Nutrition & Food Science · doi:10.1108/00346650710749062 · Cited by 17

Integrative medicine and human health ‐ the role of pre‐, pro‐ and synbiotics

Bengmark, S. (2012) · Clinical and Translational Medicine · doi:10.1186/2001-1326-1-6 · Cited by 17

Intestinal barrier function in neonatal foals: Options for improvement

Vendrig, J. C., & Fink‐Gremmels, J. (2012) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.01.032 · Cited by 17

Probiotic supplement consumption alters cytokine production from peripheral blood mononuclear cells: a preliminary study using healthy individuals

Hepburn, N. J., Garaiová, I., Williams, E. A., Michael, D. R., & Plummer, S. (2013) · Beneficial Microbes · doi:10.3920/bm2013.0012 · Cited by 17

Eating away cancer: the potential of diet and the microbiome for shaping immunotherapy outcome

Nguyen, N.-T. A., Jiang, Y., & McQuade, J. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1409414 · Cited by 19

The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research

McKenzie, N. D., Hong, H. S., Ahmad, S., & Holloway, R. W. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103165 · Cited by 16

Plant origin prebiotics affect duodenal brush border membrane functionality and morphology, in vivo ( Gallus Gallus )

da Silva, B. P., Martino, H. S. D., & Tako, E. (2021) · Food & Function · doi:10.1039/d1fo01159f · Cited by 16

Impact ofβ2-1 fructan on faecal community change: results from a placebo-controlled, randomised, double-blinded, cross-over study in healthy adults

Clarke, S. T., Brooks, S. P. J., Inglis, G. D., Yanke, L. J., Green, J., Petronella, N., Ramdath, D. D., Berčík, P., Green-Johnson, J. M., & Kalmokoff, M. L. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002318 · Cited by 16

Changes of intestinal microbiota and microbiota-based treatments in IBD

Li, Q., Zhou, S., Wang, Y., & Cong, J. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03069-4 · Cited by 16

Short fungal fractions of β-1,3 glucans affect platelet activation

Vancraeyneste, H., Charlet, R., Guérardel, Y., Choteau, L., Bauters, A., Tardivel, M., François, N., Dubuquoy, L., Soloviev, D. A., Poulain, D., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00907.2015 · Cited by 15

Inflammatory Bowel Disease

Munsell, M. A., & Mullin, G. E. (2009) · CRC Press eBooks · doi:10.1201/9781420067637.ch14 · Cited by 15

Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?

Balan, Y., Archana Gaur, T., Sakthivadivel, V., Kamble, B. D., & Sundaramurthy, R. (2021) · Cureus · doi:10.7759/cureus.19740 · Cited by 14

Functional foods for the gut: probiotics, prebiotics and synbiotics

Drakoularakou, A., Rastall, R. A., & Gibson, G. R. (2011) · Elsevier eBooks · doi:10.1533/9780857092557.3.449 · Cited by 14

Exploring & exploiting our ‘other self’ – Does the microbiota hold the key to the future therapy in Crohn's?

Haag, L.-M., & Siegmund, B. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.04.001 · Cited by 14

Microbial Modulation in Inflammatory Bowel Diseases

Yu, J., & Cheon, J. H. (2022) · Immune Network · doi:10.4110/in.2022.22.e44 · Cited by 13

[Impact of nutritional treatment in the evolution of inflammatory bowel disease].

Ballesteros-Pomar, M. D., Casariego, A. V., Fernández, A. C., Gómez, J. J. L., Fondo, A. U., & Rodríguez, I. C. (2010) · PubMed · Cited by 13

From traditional to artificial intelligence-driven approaches: Revolutionizing personalized and precision nutrition in inflammatory bowel disease

Baldi, S., Sarikaya, D., Lotti, S., Cuffaro, F., Fink, D., Colombini, B., Sofi, F., & Amedei, A. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.05.012 · Cited by 13

The Gut Microbiota and Inflammatory Bowel Disease

Conrad, M. A., Wu, G. D., & Kelsen, J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-49215-5_4 · Cited by 12

Chicory Inulin: A Versatile Biopolymer with Nutritional and Therapeutic Properties

Malik, B., & Rehman, R. U. (2021) · Springer eBooks · doi:10.1007/978-3-030-58975-2_16 · Cited by 12

Inflammatory Bowel Disease

Parian, A. M., Mullin, G. E., Langhorst, J., & Brown, A. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00050-5 · Cited by 15

Nutraceuticals and Diet Supplements in Crohn’s Disease: A General Overview of the Most Promising Approaches in the Clinic

Conno, B. D., Pesce, M., Chiurazzi, M., Andreozzi, M., Rurgo, S., Corpetti, C., Seguella, L., Re, A., Palenca, I., Esposito, G., et al. (2022) · Foods · doi:10.3390/foods11071044 · Cited by 12

Prebiotics in Inflammatory Bowel Diseases

Guarner, F. (2008) · CRC Press eBooks · doi:10.1201/9780849381829.ch18 · Cited by 12

Potential of probiotics as pharmaceutical agent: a review

Sarkar, S. (2013) · British Food Journal · doi:10.1108/bfj-06-2011-0163 · Cited by 13

Prebiotics

Crittenden, R. G., & PLAYNE, M. J. (2008) · Wiley eBooks · doi:10.1002/9780470432624.ch7 · Cited by 13

High-yield production and purification of prebiotic inulin-type fructooligosaccharides

Wienberg, F., Hövels, M., & Deppenmeier, U. (2022) · AMB Express · doi:10.1186/s13568-022-01485-9 · Cited by 11

Consumption of yacon flour and energy-restricted diet increased the relative abundance of intestinal bacteria in obese adults

Ribeiro, P. V. D. M., Veloso, T. G. R., de Oliveira, L. L., Mendes, N. P., & Alfenas, R. D. C. G. (2023) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-01140-w · Cited by 12

Pathophysiology of Inflammatory Bowel Diseases

Hoentjen, F., & Dieleman, L. A. (2008) · CRC Press eBooks · doi:10.1201/9780849381829.ch17 · Cited by 11

The synergic impact of lignin and Lactobacillus plantarum on DSS-induced colitis model via regulating CD44 and miR 199a alliance

Kaliyamoorthy, V., Jacop, J. P., Thirugnanasambantham, K., Ibrahim, H.-I. M., & Kandhasamy, S. (2022) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-022-03424-z · Cited by 11

The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond

Chiriac, M. T., Mahapatro, M., Neurath, M. F., & Becker, C. (2017) · Visceral Medicine · doi:10.1159/000470892 · Cited by 11

The prebiotic potential of dietary onion extracts: shaping gut microbial structures and promoting beneficial metabolites

Yoo, Y., Kim, S., Lee, W., Kim, J., Son, B., Lee, K. J., & Shin, H. (2024) · mSystems · doi:10.1128/msystems.01189-24 · Cited by 10

Prebiotic Carbohydrates for Therapeutics

Basavaiah, R., & Gurudutt, P. S. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200929140522 · Cited by 10

Fecal Microbiota Transplantation Combined with Prebiotics Ameliorates Ulcerative Colitis in Mice

Qian, X., Jiang, H., Yao, W., Shao, H., He, W., He, Y., Bao, X., He, L., Jia, Y., & Xu, Z. (2023) · Future Microbiology · doi:10.2217/fmb-2023-0001 · Cited by 11

CARACTERIZACIÓN FÍSICA, NUTRICIONAL Y NO NUTRICIONAL DE LAS SEMILLAS DE INGA PATERNO

Sánchez-Mendoza, N. A., Jiménez‐Martínez, C., Cardador‐Martínez, A., del Campo, S. T. M., & Dávila-Ortíz, G. (2016) · Revista chilena de nutrición · doi:10.4067/s0717-75182016000400010 · Cited by 10

Dietary Fiber and Gastrointestinal Disease: an Evolving Story

O’Grady, J., & Shanahan, F. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0667-0 · Cited by 10

Putting the microbiota to work: Epigenetic effects of early life antibiotic treatment are associated with immune-related pathways and reduced epithelial necrosis following Salmonella Typhimurium challenge in vitro

Costa, M. D. O., Fouhse, J. M., Silva, A. P. S. P., Willing, B. P., & Harding, J. C. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231942 · Cited by 11

Inulin-Type Fructans

Loo, J. V., & Bosscher, D. (2014) · ASM Press eBooks · doi:10.1128/9781555815462.ch11 · Cited by 10

Novel therapeutic modalities in pediatric inflammatory bowel disease.

Shteyer, E., & Wilschanski, M. A. (2008) · PubMed · Cited by 10

Dietary Fiber Information for Individuals With Crohn Disease

Brotherton, C., & Taylor, A. G. (2013) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3182a67a9a · Cited by 10

Antioxidant and Anti-Inflammatory Phytochemicals for the Treatment of Inflammatory Bowel Disease: A Systematic Review

Pantalos, G., Vaou, N., Papachristidou, S., Stavropoulou, E., Tsigalou, C., Voidarou, C. C., & Bezirtzoglou, E. (2024) · Applied Sciences · doi:10.3390/app14052177 · Cited by 9

Gut–Oral Microbial Dysbiosis: A Correlated Ecosystem

Siddiqui, Z. R., Rahman, S., Verma, N., Srivastava, A. K., Jahan, N., Mohanty, S., & Suman, S. (2025) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/7351229 · Cited by 10

Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for “Gibsons’ Conundrum”

Fung, Q. M., & Szilagyi, A. (2012) · International Journal of Inflammation · doi:10.1155/2012/493717 · Cited by 9

Prebiotics: future trends in health care

Singh, R., Sharma, P. K., & Malviya, R. (2011) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-011-0065-8 · Cited by 9

Specific considerations in the treatment of pediatric inflammatory bowel disease

Grossman, A. B., & Baldassano, R. N. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.1.105 · Cited by 9

Anti‐inflammatory effect a specific Lactiplantibacillus plantarum in an ovalbumin‐induced asthma model

Kishida, S., Kato‐Mori, Y., Okamoto, M., & Hagiwara, K. (2022) · Microbiology and Immunology · doi:10.1111/1348-0421.13014 · Cited by 9

The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre

Hart, A. L., & Hendy, P. (2014) · Proceedings of The Nutrition Society · doi:10.1017/s0029665114001153 · Cited by 9

Mild to Moderate Crohn’s Disease

Wong, K., & Bressler, B. L. (2008) · Drugs · doi:10.2165/0003495-200868170-00002 · Cited by 9

A fruktóz és a fruktózintolerancia

Buzás, G. M. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30567 · Cited by 9

Immune Response of Fructo and Galacto‐Oligosaccharides

Vijayasarathy, M., Prabhu, Y. A., Pavithra, S., Prabha, S. J., & Rao, T. J. M. (2022) · Wiley eBooks · doi:10.1002/9781394167227.ch2 · Cited by 9

Modulation of anxiety-like behavior in galactooligosaccharide-fed mice: A potential role for bacterial tryptophan metabolites and reduced microglial reactivity

Spencer, K. D., Bline, H., Chen, H. J., Verosky, B. G., Hilt, M. E., Jaggers, R. M., Gur, T., Mathé, E. A., & Bailey, M. T. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.024 · Cited by 9

Alternative Approaches to Counter Multidrug-Resistant Bacterial Pathogens

Saxena, D., Maitra, R., Dasgupta, A., & Chopra, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5272-0_5 · Cited by 8

Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed

LARUSSA, T., Abenavoli, L., FABIANO, G., MANCUSO, M. A., POLIMENI, N., DUMITRASCU, D. L., & Luzza, F. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02907-7 · Cited by 8

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease

Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A., Ng, S. C., McCarthy, N. E., Hart, A. L., Kamm, M. A., Sanderson, J. D., Knight, S. C., Forbes, A., et al. (2011) · Gut · doi:10.1136/gut.2010.232025 · Cited by 361

FOSter your intestinal flora: Prebiotics for Crohnʼs disease

Katz, J. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000218766.84087.99

T2020 No Clinical Benefit of Prebiotics in the Treatment of Active Crohn's Disease: A Double-Blind, Randomised, Placebo-Controlled Trial

Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A. L., Ng, S. C., Hart, A. L., Kamm, M. A., Sanderson, J. D., Knight, S. C., Forbes, A., Stagg, A. J., et al. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)62833-8 · Cited by 2

A5 FRUCTOOLIGOSACCHARIDE EXACERBATES INFLAMMATION AND THE LOSS OF MICROBIAL DIVERSITY FOLLOWING ILEOCECAL RESECTION IN A MURINE MODEL OF POST-OPERATIVE CROHN’S DISEASE RECURRENCE

Laffin, M., Perry, T., Hotte, N., Park, H., Fedorak, R. N., Dicken, B. J., & Madsen, K. L. (2018) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwy008.006 · Cited by 1

OC-003 No clinical benefit of prebiotics in the treatment of active Crohn's disease: a double-blind, randomised, placebo-controlled trial:

Benjamin, J. L., Hedin, C. R. H., Koutsoumpas, A. L., Ng, S. C., Hart, A., Kamm, M. A., Sanderson, J. D., Knight, S. C., Forbes, A., Stagg, A. J., et al. (2010) · Gut · doi:10.1136/gut.2009.208934c · Cited by 4